Resmed Corp
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$903Kgeneral payments (2019-2025)
$14Kresearch payments (2019-2025)
4,014clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Michael Fleming | Shreveport, LA | Family Medicine | $165,052.38 |
| Atul Malhotra | San Diego, CA | Sleep Medicine (Internal Medicine) | $119,455.17 |
| Lee Fleisher | Philadelphia, PA | Anesthesiology | $101,000.00 |
| Emerson Wickwire | Baltimore, MD | $70,180.00 | |
| Vrushali Gersappe | Everett, WA | Sleep Medicine (Psychiatry & Neurology) | $55,653.84 |
| Jagdeep Bijwadia | Rochester, MN | Pulmonary Disease | $51,392.58 |
| Joseph Ojile | Saint Louis, MO | Pulmonary Disease | $26,038.75 |
| Douglas Kirsch | Charlotte, NC | Sleep Medicine (Psychiatry & Neurology) | $16,080.00 |
| Virend Somers | Rochester, MN | Cardiovascular Disease | $16,059.40 |
| Cleland Landolt | San Diego, CA | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $15,700.00 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.